Curated News
By: NewsRamp Editorial Staff
September 02, 2026

Hartig Drug Adds Nefense Nasal Care Line in Three States

TLDR

  • Hartig Drug adds Nefense nasal sprays across three states, offering a drug-free edge in the nasal care market.
  • Nefense products use hypochlorous acid and xylitol in sprays for adults, children, and infants, supported by clinical research.
  • Hartig Drug expands access to Nefense, providing gentle, non-medicated nasal care options for families in the Midwest.
  • Nefense includes hypoallergenic sprays for infants and kids, plus a xylitol option, making daily nasal hygiene a breeze.

Impact - Why it Matters

This news matters because it expands consumer access to drug-free nasal hygiene products, offering families in Iowa, Illinois, and Wisconsin a natural alternative to decongestants. With options for adults, children, and infants, Nefense products address a growing preference for non-medicated solutions, potentially reducing reliance on over-the-counter drugs and supporting proactive health management. For Hartig Drug, it reinforces its role as a community health partner, while for Nefense, it marks a significant retail milestone that could pave the way for wider distribution.

Summary

Hartig Drug Company, a family-owned pharmacy and retail chain based in Dubuque, Iowa, has expanded its product lineup by adding Nefense® nasal care products at select locations in Iowa, Illinois, and Wisconsin. This move offers customers new drug-free options for daily nasal hygiene, catering to a growing demand for non-medicated alternatives. The Nefense lineup features hypochlorous acid nasal sprays for adults, children, and infants, plus a xylitol spray, providing non-medicated alternatives to decongestants across age groups. These products are now available at participating Hartig Drug stores, giving shoppers access to innovative nasal wellness solutions.

Founded in 1904, Hartig Drug Company has a long history of serving communities with personalized pharmacy services and health products. By partnering with Nefense, a Dubuque-based nasal wellness company, Hartig Drug reinforces its commitment to offering diverse health solutions. Nefense, developed under the direction of Richard Downs, DDS, focuses on daily nasal hygiene and airway care with products like HypoNasal, HypoNasal Junior, HypoBaby, and XyloClean. Published randomized clinical research evaluates low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, although these studies do not test Nefense-branded products. For more details, click here to view the full announcement.

This expansion aligns with a broader trend toward preventive healthcare and natural wellness. Hartig Drug's decision to stock Nefense products underscores its dedication to meeting customer needs with safe, effective, and drug-free options. As consumers increasingly seek alternatives to traditional medications, this partnership positions both companies at the forefront of the nasal care market, potentially influencing other retailers to follow suit.

Source Statement

This curated news summary relied on content distributed by Reportable. Read the original source here, Hartig Drug Adds Nefense Nasal Care Line in Three States

Blockchain registration record for this content